Biden's Executive Order, Dems Digital Money Legislation, First Step To

From Monetary Gold | Ad

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.

ATYR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.70%

Insider Buying (Last 12 Months): $172,369.48

Insider Selling (Last 12 Months): $0.00

Atyr PHARMA Insider Trading History Chart

Atyr PHARMA Share Price & Price History

^$1.90

▲ +0.08 (4.40%)

As of 09/19/2024 01:44 PM ET

Days: 30 | 90 | 365

Central Bank Abandons USD

From True Gold Republic | Ad

Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.

Click here now to get your free 'Protect Your Wealth' Guide.

Atyr PHARMA Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/24/2024	Paul Schimmel	Director	Buy	52,300	$1.93	$100,939.00	413,023
7/22/2024	Paul Schimmel	Director	Buy	41,052	$1.74	$71,430.48	354,075

China Stockpiling Gold “Like No Tomorrow”

From True Gold Republic | Ad

For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .

Click here now to get your free 'De-Dollarization' Guide.

SEC Filings (Institutional Ownership Changes) for Atyr PHARMA (NASDAQ:ATYR)

61.72% of Atyr PHARMA stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Read More

Today's Range

Now: $1.90

$1.85

$1.90

50 Day Range

MA: $1.87

$1.64

$2.23

52 Week Range

Now: $1.90

$1.08

$2.50

Volume

107,487 shs

Average Volume

462,516 shs

Market Capitalization

$131.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of Atyr PHARMA?: Atyr PHARMA's top insider shareholders include:
Paul Schimmel (Director)
Learn More about top insider investors at Atyr PHARMA.

Biden's Executive Order, Dems Digital Money Legislation, First Step To

From Monetary Gold | Ad

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.